DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution 5 mg/1.5 mg per 5 ml. Hydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough in adults and children ages 6 and older. A combination medication, the
DUBLIN, Ireland — Perrigo Co. plc is bringing in methamphetamine-blocking capability for pseudoephedrine (PSE) products. On Tuesday, Perrigo said it has entered an exclusive licensing agreement with St. Louis-based Highland Pharmaceuticals for its Tarex meth-blocking technology. The deal also includes the distribution rights of Zephrex-D, the pseudoephedrine nasal decongestant marketed by Highland’s Westport Pharmaceuticals unit.
DUBLIN, Ireland — Perrigo Co. plc plans to acquire Geiss, Destin & Dunn Inc., a U.S. distributor of over-the-counter health care, personal care and consumer products. Financial terms of the deal weren’t disclosed. Perrigo said Wednesday that it expects to finalize the Geiss, Destin & Dunn (GDD) transaction by the end of August. Based in
DUBLIN, Ireland — Perrigo Co. plc has wrapped up the sale of its U.S. vitamins, minerals and supplements (VMS) business to International Vitamin Corp. (IVC). The cash deal, terms of which weren’t disclosed, was announced in late June. The VMS business was part of the Perrigo Nutritionals division, whose core products are store-brand infant formula
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for omeprazole and sodium bicarbonate capsules 20 mg/1100 mg, an over-the-counter medicine for heartburn. Perrigo said Monday that its product marks the first store-brand launch of an equivalent to Bayer’s Zegerid OTC capsules. Shipments to retail customers are under way,
DUBLIN, Ireland — Perrigo Co. plc plans to sell its U.S. vitamins, minerals and supplements (VMS) business to International Vitamin Corp. (IVC). Financial terms of the deal weren’t disclosed. Perrigo said Monday that the company had been looking to sell off its VMS business and that it expects the transaction to close by early August,
DUBLIN, Ireland — Perrigo Co. and Allergan plc have rolled out guaifenesin 1,200-mg and dextromethorphan HBr 60-mg extended-release tablets, a combination expectorant and cough suppressant. The companies said Tuesday that the product marks the first over-the-counter store-brand equivalent to Mucinex DM 1,200-mg ER tablets from Reckitt Benckiser (RB) for retail and wholesale customers. First shipments
NEW YORK — Joseph Papa has resigned as chairman and chief executive officer of Perrigo Co. plc to join Valeant Pharmaceuticals International Inc. as chairman and CEO. Valeant said Monday that Papa, 60, is slated to start at the company by early May. Papa will succeed J. Michael Pearson, who is expected to remain as
DUBLIN, Ireland — Perrigo Co. plc has begun shipping a store-brand version of Abbott’s Glucerna aseptic nutritional shake for adults with diabetes. Perrigo said Tuesday that its product represents a first-to-market launch of an over-the-counter, private-brand equivalent to Glucerna. The company said its product is packaged and marketed as a store brand or retailer “own
WASHINGTON — The Consumer Healthcare Products Association (CHPA) has elected officers and members to its board of directors. CHPA said Wednesday that Patrick Lockwood-Taylor, vice president of Personal Health Care North America and Digestive Wellness Design for Procter & Gamble Co., will continue to serve as chairman. Jeffrey Needham, executive vice president and general manager
HERTFORDSHIRE, England — Mylan N.V. plans to acquire Sweden-based pharmaceuticals manufacturer Meda AB in a deal valued at $9.9 billion, including debt. Mylan said late Wednesday that the offer to Meda includes cash and Mylan shares, with the equity portion valued at $7.2 billion. Executives from both companies noted that a Mylan-Meda combination would create
DUBLIN, Ireland — Perrigo Co. plc has completed its acquisition of a portfolio of generic dosage forms and strengths of acne topical treatment Retin-A from Matawan Pharmaceuticals LLC. Financial terms of deal, announced in mid-December, weren’t disclosed. Perrigo was the authorized generic distributor of these Retin-A (tretinoin) products from 2005 to 2013 before the agreement
DUBLIN, Ireland — Perrigo Co. plc has voluntarily recalled some batches of its children’s guaifenesin liquid in the United States following a recent recall of certain dosing cups by its supplier. Perrigo said Monday that the recall, to the retail level, involves two batches of its children’s guaifenesin grape liquid (100 mg/5 ml), an expectorant,
DUBLIN, Ireland — Allergan plc and Perrigo Co. plc have launched combination guaifenesin 600-mg and pseudoephedrine HCl 60-mg extended-release tablets to retail and wholesale customers. Allergan and Perrigo said Monday that the initial shipments of the new store-brand product, which began in December, mark a first-to-market achievement for the companies. “This first-to-market launch illustrates the
